Discover how RAYUS Radiology, a leading national provider of imaging services, has successfully expanded its business over a decade-long partnership with PETNET Solutions Inc, a Siemens Healthineers Company, by leveraging the industry鈥檚 most comprehensive portfolio of PET tracers and the support of industry experts averaging 20 years of experience.
In today鈥檚 complex healthcare environment, reliable and comprehensive imaging services are essential for providers and patients alike. Founded in 1981, RAYUS Radiology pioneered a unique business model, delivering high-quality patient care and treatment options via an outpatient setting. Over the decades, RAYUS expanded its outpatient services to include Hospital Solutions, bringing full-service mobile diagnostic imaging and staffing to hospitals, clinics, and healthcare organizations. RAYUS has grown to include 150 radiology centers and 161 mobile imaging units (CT, MRI, and PET) across 35 states, with PETNET serving as the preferred radiopharmacy of 52 of these mobile units. By offering mobile services like PET imaging in rural and urban areas, RAYUS is vital in helping healthcare systems deliver accessible, high-quality advanced imaging to patients nationwide.听
鈥We rely on PETNET not only to support our customers but also to keep our internal sales and operations teams informed about current industry developments and upcoming tracers in the pipeline.鈥
A new partnership
In 2014, RAYUS sought a new PET radiopharmacy provider. Initially hesitant about changing, they ultimately chose PETNET Solutions, beginning a strong, decade-long partnership. Lori Wright, VP of Market Success, is a key team member responsible for selecting vendors. Having evaluated various Fludeoxyglucose F 18 Injection (18F FDG) suppliers, she states, 鈥淧ETNET Solutions surpasses all other vendors in delivering FDG, thanks to the comprehensive range of additional services they provide.鈥 In the early years of this partnership, FDG was the primary tracer used for PET imaging, mainly in the oncology space for diagnosing, staging, and re-staging various cancers. However, in the past decade, there has been significant innovation in developing novel tracers, resulting in the approval of several FDA-approved tracers targeting specific diseases such as prostate cancer, breast cancer, and Alzheimer鈥檚 disease. Staying informed about new radiopharmaceuticals entering the market is essential for imaging centers to remain at the forefront of medical advancements, enhance patient care, and sustain competitive relevance. With its extensive radiology service footprint, RAYUS depends on a reliable radiopharmaceutical provider like PETNET Solutions. PETNET Solutions offers the most expansive PET pharmacy network, ensuring wide delivery coverage and scalable solutions to meet fluctuating demand. PETNET Solutions is more than just a radiopharmaceutical provider. With a team averaging over 20 years of industry experience, PETNET Solutions offers听expert support and is committed to collaboration, tailoring its services to the unique needs of diverse markets across the country where RAYUS offers PET/CT imaging.
More than a dose: PETNET Solutions provides valuable resources
The extensive knowledge of the PETNET Solutions sales team provides RAYUS with tools to help educate their staff and customers. 鈥淲e rely on PETNET not only to support our customers but also to keep our internal sales and operations teams informed about current industry developments and upcoming tracers in the pipeline. This insight is invaluable in guiding our budget planning and decision-making processes.鈥 Stated Lori Wright. By partnering with PETNET Solutions, RAYUS鈥 customers who choose PETNET Solutions as their PET radiopharmaceutical provider have access to an extensive portfolio of marketing materials. Access to these resources assists key decision makers, like account executives and physicians, in remaining informed and maximizing their PET program鈥檚 full potential.听
Establishing a strong business relationship from the outset lays the groundwork for mutual trust, collaboration, and long-term success. "PETNET Solutions demonstrated this commitment from the very beginning. Angela Murray, Regional Sales Director for the Northeast, established a strong connection with me on day one, aligning with my vision that clinical resources can significantly impact and guide physicians,鈥 Lori explained. She continued, 鈥淥ne of the main initiatives when we entered this contract was to provide account executives with impactful clinical collateral for customers. Simply saying we offer PET/CT as a service wasn鈥檛 enough鈥攚e needed to guide referring physicians on how to utilize PET to its full potential.鈥 Lori further highlighted PET/CT algorithms as a key resource, illustrating the patient journey and reinforcing the clinical value of PET imaging. 鈥淔ollowing the signing of our contract, we collaborated closely with PETNET, enabling us to swiftly enhance and optimize our sales collateral; now, ten years later, I estimate 99% of all our marketing collateral has been based on what PETNET has provided,鈥 Lori states.
One of the services offered by PETNET Solutions includes a market analysis to help customers optimize processes, identify new opportunities, and create an effective blueprint for growth. 鈥淏efore we add a new customer, or novel tracer, I reach out to PETNET to do a market analysis to see what the potential is and analyze the competitive landscape. This enables us to have transparent, informed discussions with the customer about their projected scan volume, helping us determine whether this is a sound business decision,鈥 Lori stated.听
As clinical indications and novel drugs enter the market, navigating complex reimbursement policies becomes increasingly challenging. PETNET Solutions addresses these complexities by actively participating in key meetings with RAYUS leadership and delivering crucial updates that influence both RAYUS and their customers. Lori Wright emphasized, "The collaboration with PETNET Solutions鈥 team, including Megan Walawender, Director of Sales Training and Programs, and Angela Murray, has been invaluable. Their industry updates and insights into pass-through status and insurance changes have been crucial for our operations and customer relations.鈥 She continues, 鈥淎lzheimer鈥檚 disease and prostate imaging is a hot topic, and the PETNET team is well-informed and equipped to help us address our concerns in real-time.鈥 These expert support actions all impact business growth, 鈥淩AYUS has seen nearly 30% increase in PET scan volume over the last four years, thanks to the support and resources provided by PETNET Solutions.鈥 Lori states.听
鈥淏efore we add a new customer, or novel tracer, I reach out to PETNET to do a market analysis to see what the potential is and analyze the competitive landscape. This enables us to have transparent, informed discussions with the customer about their projected scan volume, helping us determine whether this is a sound business decision.鈥
鈥婭nvesting in the future
Such incredible growth leaves RAYUS with a different problem: ensuring capacity. Meeting revenue expectations month after month has led leadership to invest more into their infrastructure. 鈥淲ith the support of PETNET and access to novel tracers, we have seen a significant positive impact on our business growth,鈥 stated Jamie Lodovici, a former account executive at RAYUS who now serves as a PETNET territory manager in the northeast. She emphasized the need for investment in new scanners to meet rising demand. RAYUS has purchased a Siemens Healthineers Biograph Trinion PET-CT* for a mobile unit that will service the southeast region. To further enhance their ability to provide access to under-served and high-demand areas, RAYUS is purchasing 8 additional Biograph Trinions in 2025. 鈥淚t鈥檚 not just about increased volume or revenue; we now need to invest more in new scanners to keep up with the demand,鈥 Jamie stated. Staying informed and up to date with changes in the industry is crucial for every imaging center, and RAYUS is no exception.听
PETNET Solutions offers a variety of tools to help you gain more molecular imaging knowledge and stay updated on current industry topics. Everything PET on the NET (EPOTN), a quarterly 天美影院 deployed by PETNET Solutions, offers a range of current topics associated with molecular imaging and is used by Lori and her team. 鈥淢any of us are signed up for EPOTN; we will then share with others on our team and customers. Megan will also provide updates for our internal 天美影院, sharing important details that can directly impact our business,鈥 stated Lori. Another invaluable resource is MI PET Source, PETNET鈥檚 comprehensive online education hub. This platform offers a wealth of clinical resources, including case studies, whitepapers, webinars with VOICE credit, reimbursement updates, and more鈥攎aking it a go-to tool for expanding molecular imaging expertise.
"The collaboration with PETNET Solutions' team, including Megan Walwander, Director of Sales Training and Programs, and Angela Murray, has been invaluable. Their industry updates and insights into pass-through status and insurance changes have been crucial for our operations and customer relations.鈥
Long lasting bonds
While a business鈥檚 success is critical, the expertise, passion, and dedication of the people behind it truly set it apart. At PETNET Solutions, our employees are not only experts in their respective fields but also deeply committed to understanding and addressing the unique needs of our customers. This unwavering dedication and customer-centric approach positions PETNET Solutions as a trusted leader in the PET radiopharmaceutical industry. A prime example of this commitment comes from Jamie Lodovici, who recalls a time when Megan Walawender went above and beyond to support a critical event. Jamie shared, 鈥淚 reached out to Megan to see if she could visit the cancer center for me, as I was needed at another site. Without hesitation, she stepped up and offered her time. 听It鈥檚 the little things like this that truly demonstrate the dedication and passion of PETNET鈥檚 employees. They give of themselves鈥攏ot just for the business, but for the patients we serve.鈥 This selfless dedication is just one example that exemplifies why PETNET Solutions is more than a PET radiopharmaceutical provider; they are a trusted partner in the healthcare journey, fueling the power of PET to transform patient care and drive medical innovation.
听 听听
(Left to right) Lori Wright, Vice President of Market Success, Rayus Radiology; Megan Walwander, Director of Sales Training and Programs, PETNET Solutions; Angela Murray, Regional Sales Director NE, PETNET Solutions; and Jamie Lodovici, Territory manager NE, PETNET Solutions
听
听
Visit RAYUS Radiology's website to learn more about their PET imaging program
Fludeoxyglucose F 18
Please see Indications and Important Safety Information for Fludeoxyglucose F 18 (18F FDG) Injection.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (eg, hospital size, case mix, level of IT adoption), there can be no guarantee that other customers will achieve the same results.
